Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer
Marta Falcinelli, Gheed Alhity, S. Baron, et al.
Brain Behavior and Immunity (2023) Vol. 110, pp. 1-12
Open Access | Times Cited: 21

Showing 21 citing articles:

Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
Rachel Massalee, Xuefang Cao
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer
Victória Bombarda-Rocha, Dany Silva, Allal Badr-Eddine, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 4013-4013
Open Access | Times Cited: 11
Daphnetin induces ferroptosis in ovarian cancer by inhibiting NAD(P)H:Quinone oxidoreductase 1 (NQO1)
Ning Ma, Mengwen Zhang, Jianqiang Hu, et al.
Phytomedicine (2024) Vol. 132, pp. 155876-155876
Open Access | Times Cited: 4
Stress regulatory hormones and cancer: the contribution of epinephrine and cancer therapeutic value of beta blockers
Rajan Kumar Tiwari, Shiv Govind Rawat, Siddharth Rai, et al.
Endocrine (2025)
Closed Access
IFN-γ Approaches in Tumor Suppression, Its Challenges, and Future Directions: A Review of Recent Advances
Mohammad Reza Ataherian, Nasim Hafezi, Elaheh Ferdosi-Shahandashti, et al.
Journal of Interferon & Cytokine Research (2025)
Closed Access
Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer
Yuanyuan Wang, Chenxi Hu, Tianpeng Du, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications
Nikolay E. Kushlinskii, О. В. Ковалева, Alexei Gratchev, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 500-500
Open Access
Curcumin enhances anti-tumor immunity in anaplastic thyroid carcinoma by elevating CD8+ T cell function and downregulating the AKT/mTORC1/STAT3/PD-L1 axis
Jiaojiao Zheng, Wei Liu, Xiaolong Wang, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155898-155898
Closed Access
Immunostimulatory CKb11 gene combined with immune checkpoint PD-1/PD-L1 blockade activates immune response and simultaneously overcomes the immunosuppression of cancer
Wen Nie, Yihong He, Xue Mi, et al.
Bioactive Materials (2024) Vol. 39, pp. 239-254
Open Access | Times Cited: 3
Integrin αvβ6 mediates the immune escape through regulation of PD-L1 and serves as a novel marker for immunotherapy of colon carcinoma
Jintao Yu, E Tianyu, Mingliang Zhou, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 5, pp. 2608-2625
Open Access | Times Cited: 3
Investigating the crosstalk between chronic stress and immune cells: implications for enhanced cancer therapy
Yongrong Lei, Fenghui Liao, Yichen Tian, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
The potential role of interleukins and interferons in ovarian cancer
Huldani Huldani, Sana Ali, F. Al-dolaimy, et al.
Cytokine (2023) Vol. 171, pp. 156379-156379
Closed Access | Times Cited: 7
Hypotensive drugs mitigate the high-sodium diet-induced pro-inflammatory activation of mouse macrophages in vivo
Martyna Cieślik, Spencer Strobel, Paweł Bryniarski, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116648-116648
Open Access | Times Cited: 1
Fallopian Tube-Derived High-Grade Serous Cancers Influence Ovarian Production of Norepinephrine and Generate Specific Metabolomic Signatures
Tova M. Bergsten, Hannah J. Lusk, Monica A. Haughan, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2185-2195
Closed Access | Times Cited: 1
Role of β-adrenergic signaling and the NLRP3 inflammasome in chronic intermittent hypoxia-induced murine lung cancer progression
Jianxia Sun, Xinyun Jia, Zhiqiang Zhang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
The role and mechanisms of PD-L1 in immune evasion during Talaromyces marneffei infection
Gang Wang, Wudi Wei, Qiang Luo, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111255-111255
Closed Access | Times Cited: 2
Reducing the Negative Effects of Stress
Boris Mravec
(2024), pp. 623-676
Closed Access
PD-L1+ Neutrophils mediate Susceptibility during Systemic Inflammatory Response in Non-Alcoholic Fatty Liver Disease
Cleyson da Cruz Oliveira Barros, Alexandre Kanashiro, Gabriel Victor Lucena Silva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
PD-L1+ Neutrophils mediate Susceptibility during Systemic Inflammatory Response in Non-Alcoholic Fatty Liver Disease
Cleyson da Cruz Oliveira Barros, Alexandre Kanashiro, Gabriel Victor Lucena Silva, et al.
(2024)
Open Access
PD-L1+ Neutrophils mediate Susceptibility during Systemic Inflammatory Response in Non-Alcoholic Fatty Liver Disease
Cleyson da Cruz Oliveira Barros, Alexandre Kanashiro, Gabriel Victor Lucena Silva, et al.
(2024)
Open Access
Future Direction of Cancer Neuroscience
Jami L. Saloman, Nicole N. Scheff, Brian M. Davis
Springer eBooks (2023), pp. 185-200
Closed Access | Times Cited: 1
Page 1

Scroll to top